Brand A - Search Results

1

HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Schreuder GM, Vermeulen M, d'Amaro J, Brand A. van Doorn PA, et al. Among authors: brand a. J Neuroimmunol. 1991 May;32(2):133-9. doi: 10.1016/0165-5728(91)90005-r. J Neuroimmunol. 1991. PMID: 1849516

2

Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic.

Lundkvist I, van Doorn PA, Vermeulen M, van Lint M, van Rood JJ, Brand A. Lundkvist I, et al. Among authors: brand a. Immunol Rev. 1989 Aug;110:105-17. doi: 10.1111/j.1600-065x.1989.tb00029.x. Immunol Rev. 1989. PMID: 2676844 Review.

3

Anti-neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro and in vivo by IV immunoglobulin.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Among authors: brand a. Neurology. 1988 Oct;38(10):1592-5. doi: 10.1212/wnl.38.10.1592. Neurology. 1988. PMID: 2843794

4

Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome.

Wokke JH, van Doorn PA, Brand A, Schreuder GM, Vermeulen M. Wokke JH, et al. Among authors: brand a. J Neurol. 1988 Sep;235(7):415-7. doi: 10.1007/BF00314484. J Neurol. 1988. PMID: 3265432

5

Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Among authors: brand a. Neurology. 1987 Nov;37(11):1798-802. doi: 10.1212/wnl.37.11.1798. Neurology. 1987. PMID: 3670618

6

Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).

van Schaik IN, Vermeulen M, van Doorn PA, Brand A. van Schaik IN, et al. Among authors: brand a. J Neuroimmunol. 1994 Oct;54(1-2):109-15. doi: 10.1016/0165-5728(94)90237-2. J Neuroimmunol. 1994. PMID: 7929799

7

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.

Vermeulen M, van Doorn PA, Brand A, Strengers PF, Jennekens FG, Busch HF. Vermeulen M, et al. Among authors: brand a. J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):36-9. doi: 10.1136/jnnp.56.1.36. J Neurol Neurosurg Psychiatry. 1993. PMID: 8429321 Free PMC article. Clinical Trial.

8

Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy.

van Schaik IN, Vermeulen M, van Doorn PA, Brand A. van Schaik IN, et al. Among authors: brand a. J Neurol. 1995 Sep;242(9):599-603. doi: 10.1007/BF00868814. J Neurol. 1995. PMID: 8551323

9

On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Rossi F, Brand A, van Lint M, Vermeulen M, Kazatchkine MD. van Doorn PA, et al. Among authors: brand a. J Neuroimmunol. 1990 Sep-Oct;29(1-3):57-64. doi: 10.1016/0165-5728(90)90147-f. J Neuroimmunol. 1990. PMID: 2211989

10

The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.

Brand A, Van Doorn PA, Rossi F, Kazatchkine MD, Vermeulen M. Brand A, et al. Prog Clin Biol Res. 1990;337:405-9. Prog Clin Biol Res. 1990. PMID: 2353004 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,363 results

Search Page

Filters